Recruiting Diabetic Retinopathy Studies in Redlands
A Study of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME
EYE-RES-103 is a randomized, double masked pivotal study to evaluate the efficacy and safety of 2 dose levels of EYE103 in comparison with the active control, ranibizumab, in patients with diabetic ma...
Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema
The purpose of this study is to evaluate efficacy and safety of KHK4951 eye drops in patients with DME....
About Diabetic Retinopathy Clinical Trials in Redlands
Diabetic retinopathy is a diabetes complication that affects the blood vessels in the retina and is the leading cause of blindness in working-age adults. Diabetic macular edema (DME) involves fluid accumulation in the macula. Treatment includes anti-VEGF injections, laser therapy, and blood sugar control.
There are currently 2 diabetic retinopathy clinical trials recruiting participants in Redlands, CALIFORNIA. These studies are seeking a combined 1,110 participants. Research is being sponsored by EyeBiotech Ltd., Kyowa Kirin Co., Ltd.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Diabetic Retinopathy Clinical Trials in Redlands — FAQ
Are there diabetic retinopathy clinical trials in Redlands?
Yes, there are 2 diabetic retinopathy clinical trials currently recruiting in Redlands, CALIFORNIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Redlands?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Redlands research site will contact you about next steps.
Are clinical trials in Redlands free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Redlands studies also compensate for your time and travel.
What diabetic retinopathy treatments are being tested?
The 2 active trials in Redlands are testing new therapies including novel drugs, biologics, and treatment approaches for diabetic retinopathy.
Data updated March 2, 2026 from ClinicalTrials.gov